<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Burns Trauma</journal-id><journal-id journal-id-type="iso-abbrev">Burns Trauma</journal-id><journal-title-group><journal-title>Burns &#x00026; Trauma</journal-title></journal-title-group><issn pub-type="ppub">2321-3868</issn><issn pub-type="epub">2321-3876</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30723753</article-id><article-id pub-id-type="pmc">6350396</article-id><article-id pub-id-type="publisher-id">141</article-id><article-id pub-id-type="doi">10.1186/s41038-018-0141-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Advances in the treatment of traumatic scars with laser, intense pulsed light, radiofrequency, and ultrasound</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Fu</surname><given-names>Xiujun</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Dong</surname><given-names>Jiying</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Shen</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Min</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Yao</surname><given-names>Min</given-names></name><address><email>my058@vip.sina.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0368 8293</institution-id><institution-id institution-id-type="GRID">grid.16821.3c</institution-id><institution>Department of Plastic Surgery, </institution><institution>Shanghai Ninth People&#x02019;s Hospital, Shanghai Jiao Tong University School of Medicine, </institution></institution-wrap>639 Zhizaoju Road, Shanghai, 200011 China </aff></contrib-group><pub-date pub-type="epub"><day>29</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>29</day><month>1</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>7</volume><elocation-id>1</elocation-id><history><date date-type="received"><day>23</day><month>6</month><year>2018</year></date><date date-type="accepted"><day>25</day><month>12</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Traumatic scarring is one of the most common complications after soft tissue injury caused by burns and trauma, which affects tens of millions of people worldwide every year. Traumatic scars diminish the quality of life due to disfigurement, symptoms of pain and itch, and restricted motion. The pathogenesis and pathophysiology of traumatic scar remain elusive. The management for traumatic scars is comprised of surgical and non-surgical interventions such as pressure therapy, silicone, corticosteroid, and radiotherapy, which are chosen by clinicians based on the physical examinations of scars. Recently, great progress in treating traumatic scars has been achieved by the development of novel technologies including laser, intense pulsed light&#x000a0;(IPL), radiofrequency, and ultrasound. The aim of this review article was to summarize the advances of these technologies for traumatic scars intervention.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Traumatic scars</kwd><kwd>Laser</kwd><kwd>Intense pulsed light</kwd><kwd>Radiofrequency</kwd><kwd>Ultrasound</kwd></kwd-group><funding-group><award-group><funding-source><institution>Chinese National Natural Science Foundation of China</institution></funding-source><award-id>81772118</award-id><principal-award-recipient><name><surname>Yao</surname><given-names>Min</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81501656</award-id><principal-award-recipient><name><surname>Fu</surname><given-names>Xiujun</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par12">Tens of millions of individuals acquire traumatic scars every year caused by burns and other traumatic injuries worldwide. Scarring is regarded as one of the inevitable consequences of trauma. The prevalence of hypertrophic scar, the most common type of traumatic scars, is reported as high as 70% after burn injury [<xref ref-type="bibr" rid="CR1">1</xref>]. The traumatic scars especially those on the face and neck are cosmetically unappealing due to dyschromia and irregular texture compared to the surrounding skin. Besides the cosmetic effects, there are several other morbidities associated with traumatic scars. Pruritus and pain associated with traumatic scars are major and very common morbidities. Up to 87% of burn patients especially those with hypertrophic scars report the symptom of pruritus, which disrupts sleep and daily activities [<xref ref-type="bibr" rid="CR2">2</xref>]. Restricted range of motion of the functional joints and the deformities of facial organs resulted from contracture are among the most severe morbidities. Severe linear or diffuse contracted scars usually require aggressive therapy such as surgical intervention to relieve tension and ultimately improve range of motion and correct the deformities. It should always be noticed that patients with traumatic scars are prone to having anxiety, depression, or even the serious consequence of suicide [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par13">Although the complete pathogenesis of traumatic scars needs further elucidated, the formation of pathological scars is regarded as a result of dysregulation in the process of wound healing which characterizes by an inflammatory phase, a proliferative phase, and a remodeling phase [<xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>]. The inflammation is crucial to the removal of dead tissue and the prevention of infection by neutrophils and macrophages through the actions of phagocytosis and the secretion of proteases and cytokines. A moderate amount of inflammation is vital to the wound healing process for transition from the inflammatory phase to the proliferative phase. Excessive inflammation response, resulting from infection for instance, often leads to abnormal wound healing and increases the risk of scarring [<xref ref-type="bibr" rid="CR7">7</xref>]. The proliferation phase was accomplished by the migration and proliferation of various cells. Activated by the cytokines and growth factors, such as transforming growth factor beta (TGF-&#x003b2;) and platelet-derived growth factor (PDGF) released mainly from macrophages, fibroblasts are induced to produce collagen and extracellular matrix. Angiogenesis is initiated by the function of endothelial cells in response to the upregulation of vascular endothelial growth factor (VEGF) [<xref ref-type="bibr" rid="CR8">8</xref>]. Keratinocytes from the edge of the wound and adnexal structures migrate and proliferate to make the wound healed by re-epithelialization. The remodeling phase can take up to a year or longer to complete, which is characterized by the rearrangement of granulation tissue, the replacement of collagen III by collagen I, and the contracture of the lesion through the action of myofibroblasts. During the remodeling phase, a variety of extracellular matrix (collagen and elastic fiber) and their corresponding enzyme system (matrix metalloproteinases) act to achieve the purpose of restoring normal histological structure [<xref ref-type="bibr" rid="CR9">9</xref>]. Even after remodeling for many years, the wounded tissue never regains the properties of uninjured skin. Traumatic scars, therefore, are the results of wound healing after tissue injury. The dysregulation of proliferation and apoptosis of fibroblasts, an imbalance between synthesis and degradation collagen in the extracellular matrix, and abnormal structure of epithelium are responsible for scarring [<xref ref-type="bibr" rid="CR10">10</xref>]. The early stage scars have diffuse capillaries and excessive abnormally arranged collagen fibers in histology, which manifest as red hypertrophic scars, whereas the late stage of scars has closed vessels and excessive fiber deposition, which manifest as normal color or reduced color scars with elevation, flat, or atrophy in morphology [<xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par14">Many treatment options have been developed for the management of traumatic scars, which are divided into surgical and non-surgical approaches [<xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>]. Surgical intervention is currently one of the mainstream methods for the treatment of traumatic scars. It is taken to correct the deficiencies and deformities and is especially applicable when a patient has functional impairment caused by contracture of the scar. However, as an invasive technique, surgery has a high risk of inducing the new scar formation and recurrence of scarring. For the treatment of pathological keloid scars, the recurrence rate of surgical excision without adjuvant therapy is as high as 45 to 100% [<xref ref-type="bibr" rid="CR14">14</xref>]. Non-surgical approaches for the treatment of traumatic scars include compression garments, silicone gel, intralesional therapy with steroids and other medications, radiation therapy, and laser and light therapy. The pressure therapy can improve the scar height by reducing the local blood supply and limiting the oxygen and nutrient for scar tissue, which is mainly used to prevent the further hyperplasia of scar tissue. But the clinical importance is questionable and it cannot effectively treat the scar that has been formed [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. The silicone products (silicone gel, sheet, strip, cream, spray, or foam) are thought to be capable to effectively inhibit the hyperplasia of scar by multiple mechanisms including hydration, polarization of scar tissue, and elevation of local oxygen tension. However, evidence from studies has yielded contradictory conclusions and it is challenging to come to the definitive conclusion on whether the evidence supports the use of silicone therapy [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Local injection of glucocorticoid (triamcinolone acetonide) with or without antineoplastic agents (5-fluorouracil) have been convinced to be effective in certain scar patients in terms of reducing the height and volume of scars, decreasing pain and itch, and making scars more pliable [<xref ref-type="bibr" rid="CR18">18</xref>]. The side effects of steroids and antitumor agents, however, limit their applications for scar therapy, especially for large scars. Significant benefits are observed with radiation therapy in intractable hypertrophic scar and keloid, but the safety of radiotherapy needs to be evaluated carefully to prevent the secondary radiation carcinogenesis [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par15">As traumatic scars are difficult to treat with high recurrence rate, the prevention and treatment of traumatic scars are very challenging for plastic surgeons and dermatologists. Therefore, it is very urgent to develop and explore new treatment options such as laser and light for traumatic scars and optimize the treatment protocols. In recent years, with the rapid development of laser, light, radiofrequency, and ultrasound technologies, clinicians have seen the cosmetic, symptomatic, and functional improvements for the treatment of traumatic scars by these technologies [<xref ref-type="bibr" rid="CR20">20</xref>]. These new technologies are believed to have the advantages of minimal invasion, fast recovery, and low risk for scar therapy. The current review article aimed to summarize the mechanisms and advances of the treatment of traumatic scars with technologies of laser, intense pulsed light (IPL), radiofrequency, and ultrasound (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of lasers, intense pulsed light, radiofrequency, and ultrasound for traumatic scars</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Devices</th><th>Mechanism</th><th>Clinical outcome</th></tr></thead><tbody><tr><td>Pulsed dye laser, potassium titanyl phosphate laser, and intense pulsed light</td><td>Target hemoglobin and decrease blood supply [<xref ref-type="bibr" rid="CR25">25</xref>]; increase expression of CTGF [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]</td><td>Improve scar color, texture, and pliability [<xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR28">28</xref>&#x02013;<xref ref-type="bibr" rid="CR31">31</xref>]</td></tr><tr><td>Factional lasers</td><td>Fractional photothermolysis [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>] and collagen remodeling [<xref ref-type="bibr" rid="CR38">38</xref>&#x02013;<xref ref-type="bibr" rid="CR40">40</xref>]</td><td>Improve in appearance and contracture [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR42">42</xref>&#x02013;<xref ref-type="bibr" rid="CR44">44</xref>], relieve pain and pruritus [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>], and facilitate drug delivery [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]</td></tr><tr><td>Radiofrequency devices</td><td>Create micro-plasma sparks and induce thermolysis [<xref ref-type="bibr" rid="CR51">51</xref>&#x02013;<xref ref-type="bibr" rid="CR53">53</xref>]</td><td>Effective for both hypertrophic and atrophic scars [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR54">54</xref>] and facilitate drug delivery [<xref ref-type="bibr" rid="CR57">57</xref>&#x02013;<xref ref-type="bibr" rid="CR59">59</xref>]</td></tr><tr><td>Ultrasound</td><td>Acoustic pressure and &#x0201c;hammering&#x0201d; effect [<xref ref-type="bibr" rid="CR57">57</xref>]</td><td>Adjuvant therapy for traumatic scars [<xref ref-type="bibr" rid="CR57">57</xref>&#x02013;<xref ref-type="bibr" rid="CR59">59</xref>]</td></tr></tbody></table><table-wrap-foot><p><italic>CTGF</italic> connective tissue growth factor</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec2"><title>Review</title><sec id="Sec02"><title>Classification of traumatic scars</title><p id="Par16">Traumatic scars are often classified into hypertrophic scar, atrophic scar, flat (superficial) scar, and keloid by clinicians to facilitate clinical management according to their histological and morphological characteristics [<xref ref-type="bibr" rid="CR21">21</xref>]. They are also categorized into mature and immature scars based on the growth phase, and linear and widespread scars based on the morphology [<xref ref-type="bibr" rid="CR22">22</xref>]. The characteristics of scars which are critical for the classification include pigmentation, erythema, texture, thickness, and pliability. In the consensus report for laser treatment of traumatic scars published in 2014 by Dr. Anderson et al. [<xref ref-type="bibr" rid="CR23">23</xref>], traumatic scars were classified taking considerations of scar dyschromia (i.e., erythematous, hyper-pigmented, or hypo-pigmented), scar type (i.e., hypertrophic, flat, or atrophic), body location of the scar (i.e., face, neck, or limbs), and patient characteristics (i.e., skin type and comorbid conditions). This classification aimed to guide the clinicians to choose appropriate lasers and variables for treatment and emphasized that the choice of laser should be concentrated on dyschromia and the relative scar thickness or atrophy as these features are the most prominent appearance features of traumatic scars [<xref ref-type="bibr" rid="CR23">23</xref>].</p></sec></sec><sec id="Sec3"><title>Laser and IPL for the treatment of traumatic scars</title><p id="Par17">Laser and IPL interact with tissue based on the propagation of light through the tissue and the subsequent absorption of photons with conversion to heat, pressure (photoacoustic effect), and photochemical and photobiological reactions. In 1983, Dr. Rox Anderson et al. [<xref ref-type="bibr" rid="CR24">24</xref>] from Harvard Medical School, firstly introduced the concept of selective photothermolysis of laser and light. With the appropriate wavelength, exposure time, and energy, laser and light are absorbed by hemoglobin, melanin, water, or collagen in skin specifically and the irradiated capillaries, pigment, or scar tissue are selectively affected. Since then, various laser and light devices have been developed and are prevalently used for vascular disease, pigmented disease, hair removal, and scar treatment by dermatologists and plastic surgeons. As the histological characteristics of scars of abnormal microvascular growth and abnormal collagen fibers arrangement have been observed, a variety of laser and light modalities have been developed and taken for both prevention and treatment of traumatic scars mainly based on the principles of selective photothermolysis and fractional photothermolysis.</p><sec id="Sec4"><title>Vascular targeted laser or light devices</title><p id="Par18">For the treatment of traumatic scars, pulsed dye laser (PDL), ablative and non-ablative fractional lasers, and IPL are most commonly used laser and light modalities. PDL (585&#x02009;nm or 595&#x02009;nm), 532-nm potassium titanyl phosphate laser, and IPL (400&#x02013;1200&#x02009;nm; 500&#x02013;600&#x02009;nm) target hemoglobin in red blood cells within vessels selectively and achieve the goal to close the local vessels and reduce the blood supply for the growth of scar tissue [<xref ref-type="bibr" rid="CR25">25</xref>]. To successfully destroy of scar vessels, proper pulse duration which is shorter than the thermal relaxation time of hemoglobin is required. PDL was also indicated to decrease the expression of connective tissue growth factor (CTGF) both in keloid patients [<xref ref-type="bibr" rid="CR26">26</xref>] and in the in vitro-cultured keloid fibroblasts [<xref ref-type="bibr" rid="CR27">27</xref>]. CTGF was discovered as strongly profibrotic growth factor via the tissue growth factor/ small mothers against decapentaplegic (TGF/ SMADs) pathway, which is highly expressed in keloid and hypertrophic scars.</p><p id="Par19">PDL and IPL can improve color, texture, and pliability of scars by reducing the pigmentation, vascularity, and bulk of scar tissue [<xref ref-type="bibr" rid="CR28">28</xref>]. In a clinical study by Manuskiatti et al. [<xref ref-type="bibr" rid="CR29">29</xref>], 0.45- and 40-ms pulses of 595&#x02009;nm PDL at the same fluence of 7&#x02009;J/cm<sup>2</sup> were compared for the treatment of keloidal and hypertrophic median sternotomy scars. The pulse width of 0.45&#x02009;ms was proven to be more effective than 40&#x02009;ms in terms of decreasing scar size and improving scar pliability [<xref ref-type="bibr" rid="CR29">29</xref>]. PDL treatments at 6-week intervals were integrated into compression therapy in patients from a pediatric burn facility [<xref ref-type="bibr" rid="CR30">30</xref>]. Less quantitative scar erythema and height and greater tissue elasticity were observed after 2&#x02013;3 PDL treatments plus compression than with compression alone. PDL given as early as on the day of suture removal to treat the linear operative scars effectively improved the quality and cosmetic appearance [<xref ref-type="bibr" rid="CR31">31</xref>]. The laser treatment consensus for traumatic scars published in JAMA Dermatology in 2014 [<xref ref-type="bibr" rid="CR23">23</xref>] believes that if traumatic scars have erythema, the vascular laser (PDL) and light (IPL) devices are initially chosen, and the factional lasers have obvious and synergistic effects with them in the treatment of hypertrophic scars with erythema. Treatment with these devices can be completed without anesthesia, and downtime as well as erythema after treatment is not significant. Cooling is mandated to prevent the side effects of epidermal damage and new scar formation. Special caution is needed when darker-toned scar patients are treated with these devices as the light energy can be competitively absorbed by melanin, which might increase the risk of dyspigmentation [<xref ref-type="bibr" rid="CR32">32</xref>].</p></sec><sec id="Sec5"><title>Fractional lasers</title><p id="Par20">By applying a new concept of skin treatment called fractional photothermolysis, fractional laser creates numerous microscopic thermal injury zones of controlled width (less than 500&#x02009;&#x003bc;m), depth, and density that are surrounded by a reservoir of spared epidermal and dermal tissue, allowing for rapid repair of laser-induced thermal injury [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. This technology enables high-energy treatment while minimizing risks of hypo-pigmentation and scarring [<xref ref-type="bibr" rid="CR35">35</xref>]. Ablative fractional lasers, including 10,600&#x02009;nm carbon dioxide laser and 2940&#x02009;nm erbium: yttrium-aluminum-garnet (Er:YAG) laser, use water as the target chromophore and produce columns of vaporized tissue with surrounding eschar and coagulated tissue. The vaporized columns are filled by epidermal cells with complete continuity 48&#x02009;h post-ablation, and heat shock proteins (Hsp-72 and Hsp-42) are elevated for months [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR37">37</xref>]. In histology, mature burn scars treated with fractional carbon dioxide laser demonstrated a return toward a fetal collagen profile, with increased type III collagen and decreased type I collagen [<xref ref-type="bibr" rid="CR38">38</xref>]. The collagen architecture in treated scars was also more closely resembling that of a normal skin [<xref ref-type="bibr" rid="CR38">38</xref>]. The induction of molecular changes including increased expression of TGF-&#x003b2;3 and matrix metalloproteinase-1 and decreased expression of basic fibroblast growth factor might be accountable for the process of collagen modeling caused by fractional carbon dioxide laser treatment [<xref ref-type="bibr" rid="CR39">39</xref>]. Non-ablative fractional lasers, e.g., erbium: glass lasers with a wavelength of 1550&#x02009;nm or 1540&#x02009;nm, create columns of coagulated tissue composed of denatured collagen while leaving the epidermal layer intact [<xref ref-type="bibr" rid="CR20">20</xref>]. Scar treated with non-ablative fractional laser shows an interwoven collagen structure with an overall increased similarity to normal unaffected skin post-treatment [<xref ref-type="bibr" rid="CR40">40</xref>], which was postulated as the subsequence collagen remodeling response induced by columnar coagulation. Although remodeling of collagen induced by fractional lasers has been well accepted, the detailed mechanism underlying this process has yet been fully elucidated.</p><p id="Par21">Currently, a variety of ablative fractional and non-ablative fractional lasers have been developed and they are widely used for the treatment of traumatic scars to improve the appearance and minimize the associated pain and pruritus [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. The ablative fractional lasers, as well as non-ablative fractional lasers, have been supported to have functional improvement as well for the treatment of scar contracture by significant evidence [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR42">42</xref>&#x02013;<xref ref-type="bibr" rid="CR44">44</xref>]. Combined with surgical scar revision, fractional lasers could induce scar rehabilitation and may eventually decrease the need for scar excision and reduce the morbidity of donor sites [<xref ref-type="bibr" rid="CR23">23</xref>]. By creating a matrix of microscopic channels penetrating stratum corneum, ablative fractional laser-assisted therapy is increasingly used to enhance drug delivery and intensify the efficacy of topically applied drugs for scar treatment [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Early intervention with PDL or fractional lasers (within weeks or months post injury) may be advantageous in mitigating scar contracture formation and trajectory with significant benefits in-patient rehabilitation, representing a potential breakthrough in the treatment of traumatic scars [<xref ref-type="bibr" rid="CR23">23</xref>]. Surgical scars have been successfully treated using PDL, non-ablative fractional laser, or ablative fractional laser with positive results on the suture removal day or weeks post suture removal day, indicating intervention with laser and light might be applied as a safe and effective treatment to prevent traumatic scarring [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. In another randomized, controlled, evaluator-blinded clinical trial, a single non-ablative fractional laser treatment at low to medium fluence performed 1&#x02009;day prior or in the early phase of wound healing provided subtle but clinically detectable improvement, which indicates laser treatment may have the potential to optimize scar formation in full-thickness wound [<xref ref-type="bibr" rid="CR49">49</xref>]. The authors recommend initiating the intervention with laser and light as early as possible to prevent the formation of traumatic scar base on the clinical experience and research study with the management of surgical sutures with laser and light (unpublished data).</p><p id="Par22">Compared with full-field lasers, fractional laser therapy for traumatic scars is associated with a relatively low rate of complications [<xref ref-type="bibr" rid="CR23">23</xref>]. Common adverse effects include transient erythema and localized swelling. Pinpoint bleeding and mild serious discharge might occur. Prolonged erythema, post-procedure pain requiring medications, scar exfoliation, infection, and transient post-inflammatory hyperpigmentation are rare in fractional laser treated traumatic scar patients. Nevertheless, the severe complications of new scarring and worsening of scarring were reported [<xref ref-type="bibr" rid="CR50">50</xref>].</p></sec></sec><sec id="Sec6"><title>Radiofrequency for the treatment of traumatic scars</title><p id="Par23">Micro-plasma radiofrequency was developed as a minimally ablative technology. It utilizes the radiofrequency energy to provoke the nitrogen in the air to form a grid of high-energy foci called plasma sparks, which release heat as they return to the steady state and induce mild ablation of the epidermis and the formation of micro-channels of the dermis on scar tissue [<xref ref-type="bibr" rid="CR51">51</xref>&#x02013;<xref ref-type="bibr" rid="CR53">53</xref>].</p><p id="Par24">In recent years, combined with the fractional technology, micro-plasma radiofrequency has achieved good outcomes for the treatment of traumatic scars as well as acne scars [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. Comparable to the ablative fractional laser, the fractional micro-plasma radiofrequency technology (FMRT) has been emerging as a technology, characterizing with both ablation and thermal coagulation, which is capable to induce the neogenesis of collagen and remodeling of epidermis and dermis. Histological studies show that FMRT creates superficial and broad &#x0201c;crater&#x0201d;-like micro-channels, while the fractional carbon dioxide laser produces narrow and deep &#x0201c;cone&#x0201d;-like micro-channels [<xref ref-type="bibr" rid="CR55">55</xref>]. Micro-plasma radiofrequency is also effective and safe for the treatment of post-burn hyperpigmentation, indicating its application for the treatment of traumatic scars in patients with Fitzpatrick skin type III or IV [<xref ref-type="bibr" rid="CR51">51</xref>], whereas hyperpigmentation has been considered as a major adverse effect associated with laser treatment in those patients.</p><p id="Par25">It is important to note that, although micro-plasma radiofrequency is believed to be a safe technology for traumatic scars therapy with minimal complications, it is critical to apply local cooling immediately post procedures as it is accompanied with local heat accumulation in treated tissues.</p></sec><sec id="Sec7"><title>Drug delivery and ultrasound for traumatic scar therapy</title><p id="Par26">Global efforts have been put, reported in a myriad of studies, to clarify the mechanisms responsible for scar formation and emerging evidence has pointed to drug delivery of targeting molecule signaling as a promising avenue for scar therapy. An article has been published in which the relative studies on drug delivery for scar management were thoroughly reviewed and discussed [<xref ref-type="bibr" rid="CR56">56</xref>]. Moreover, innovative technologies for drug delivery, such as transepidermal drug delivery (TED), provide an attractive alternative way to conventional injection with needle, which is painful and results in uneven distribution of medications. Both ablative fractional laser and micro-plasma radiofrequency have the capacity to create arrays of micro-channels on the scar, through which the therapeutic medications can be delivered into the deep layer of thick scar tissue efficiently and safely. Therefore, triamcinolone acetonide, 5-fluorouracil, collagenase, platelet-rich plasma, poly-<sc>l</sc>-lactic acid, and other medications or substances are often applied topically in the immediate postoperative period after fractional laser or micro-plasma treatment as the combination therapies for both hypertrophic and atrophic traumatic scars for better clinical outcomes [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>].</p><p id="Par27">Recently, ultrasound technology has been incorporated to further facilitate the penetration of anti-scarring drugs into dermis through the micro-channels produced by micro-plasma radiofrequency. Ultrasound improves the delivery of therapeutic medications through mechanical (acoustic) pressure and torques by propagation of the ultrasound wave via the sonotrode to the distal horn and the creation of a &#x0201c;hammering&#x0201d; effect [<xref ref-type="bibr" rid="CR57">57</xref>]. The combination therapy of micro-plasma radiofrequency with ultrasound was confirmed as an effective treatment method for both hypertrophic and atrophic scars with satisfactory results without the complications inherent in other methods [<xref ref-type="bibr" rid="CR57">57</xref>&#x02013;<xref ref-type="bibr" rid="CR59">59</xref>]. The action mechanisms of micro-plasma radiofrequency or ablative fractional laser are completely different to ultrasound, and the combination can achieve a synergic action. Ultrasound technology aimed for drug delivery keeps on moving forward. It is worthwhile to mention that the combination of low-frequency ultrasound with advanced nanotechnology developed by Paithankar et al. [<xref ref-type="bibr" rid="CR60">60</xref>] provides a very promising way for future traumatic scar therapy based on selective thermal effect.</p></sec><sec id="Sec8"><title>Conclusion</title><p id="Par28">Laser, IPL, radiofrequency, and ultrasound-assisted medication delivery technologies alone or combined, have been proved to effectively and safely improve the appearance of the traumatic scars (thickness, texture, erythema, and pigmentation), decrease pain and itch, alleviate the contracture and improve function, and reduce the need for surgical excision. Both fractional lasers and radiofrequency devices can be applied solely for the treatment of both hypertrophic and atrophic traumatic scars. Vascular targeted devices PDL and IPL are solely or combined with fractional laser indicated for erythematous traumatic scars. Ultrasound is utilized as an adjuvant therapy with radiofrequency or fractional laser mainly for hypertrophic traumatic scars. Nevertheless, the cellular and molecular mechanisms responsible for the repairing and remodeling response to microscopic thermal injury introduced by fractional laser and radiofrequency therapies are elusive. Furthermore, treatment of traumatic scars with these technologies has not been optimized, and the efficacy and long-term outcome of these technologies have yet been compared until now. Therefore, both basic research to explore thoroughly the mechanisms, as well as randomized controlled clinical trials to explore the optimal treatment protocols, should be completed. The better understanding of these technologies will promote the appropriate implementation of these technologies in clinical practice for traumatic scars treatment.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CTGF</term><def><p id="Par2">Connective tissue growth factor</p></def></def-item><def-item><term>Er:YAG</term><def><p id="Par3">Erbium: yttrium-aluminum-garnet</p></def></def-item><def-item><term>Hsp</term><def><p id="Par4">Heat shock protein</p></def></def-item><def-item><term>IPL</term><def><p id="Par5">Intense pulsed light</p></def></def-item><def-item><term>PDGF</term><def><p id="Par6">Platelet-derived growth factor</p></def></def-item><def-item><term>PDL</term><def><p id="Par7">Pulsed dye laser</p></def></def-item><def-item><term>SMADs</term><def><p id="Par8">Small mothers against decapentaplegic</p></def></def-item><def-item><term>TED</term><def><p id="Par9">Transepidermal drug delivery</p></def></def-item><def-item><term>TGF-&#x003b2;</term><def><p id="Par10">Transforming growth factor beta</p></def></def-item><def-item><term>VEGF</term><def><p id="Par11">Vascular endothelial growth factor</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>Not applicable</p><sec id="FPar1"><title>Funding</title><p id="Par29">This work was supported by the National Natural Science Foundation of China (No. 81772118, and 81501656).</p></sec><sec id="FPar2" sec-type="data-availability"><title>Availability of data and materials</title><p id="Par30">Not applicable.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>XF drafted the manuscript. All authors contributed to the conception of this review paper and participated in the editing and revision. All authors read and approved the final manuscript.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p>Not applicable.</p></sec><sec id="FPar4"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar5"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bombaro</surname><given-names>KM</given-names></name><name><surname>Engrav</surname><given-names>LH</given-names></name><name><surname>Carrougher</surname><given-names>GJ</given-names></name><name><surname>Wiechman</surname><given-names>SA</given-names></name><name><surname>Faucher</surname><given-names>L</given-names></name><name><surname>Costa</surname><given-names>BA</given-names></name><etal/></person-group><article-title>What is the prevalence of hypertrophic scarring following burns?</article-title><source>Burns</source><year>2003</year><volume>29</volume><issue>4</issue><fpage>299</fpage><lpage>302</lpage><pub-id pub-id-type="pmid">12781605</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brooks</surname><given-names>JP</given-names></name><name><surname>Malic</surname><given-names>CC</given-names></name><name><surname>Judkins</surname><given-names>KC</given-names></name></person-group><article-title>Scratching the surface--managing the itch associated with burns: a review of current knowledge</article-title><source>Burns</source><year>2008</year><volume>34</volume><issue>6</issue><fpage>751</fpage><lpage>760</lpage><pub-id pub-id-type="pmid">18375072</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Loey</surname><given-names>NE</given-names></name><name><surname>Van Son</surname><given-names>MJ</given-names></name></person-group><article-title>Psychopathology and psychological problems in patients with burn scars: epidemiology and management</article-title><source>Am J Clin Dermatol</source><year>2003</year><volume>4</volume><issue>4</issue><fpage>245</fpage><lpage>272</lpage><pub-id pub-id-type="pmid">12680803</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niessen</surname><given-names>FB</given-names></name><name><surname>Spauwen</surname><given-names>PH</given-names></name><name><surname>Schalkwijk</surname><given-names>J</given-names></name><name><surname>Kon</surname><given-names>M</given-names></name></person-group><article-title>On the nature of hypertrophic scars and keloids: a review</article-title><source>Plast Reconstr Surg</source><year>1999</year><volume>104</volume><issue>5</issue><fpage>1435</fpage><lpage>1458</lpage><pub-id pub-id-type="pmid">10513931</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>B</given-names></name><name><surname>Maderal</surname><given-names>A</given-names></name><name><surname>Raphael</surname><given-names>B</given-names></name></person-group><article-title>Keloids and hypertrophic scars: pathophysiology, classification, and treatment</article-title><source>Dermatol Surg</source><year>2017</year><volume>43</volume><issue>1</issue><fpage>S3</fpage><lpage>S18</lpage><pub-id pub-id-type="pmid">27347634</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Profyris</surname><given-names>C</given-names></name><name><surname>Tziotzios</surname><given-names>C</given-names></name><name><surname>Do</surname><given-names>VI</given-names></name></person-group><article-title>Cutaneous scarring: pathophysiology, molecular mechanisms, and scar reduction therapeutics part I. The molecular basis of scar formation</article-title><source>J Am Acad Dermatol</source><year>2012</year><volume>66</volume><issue>1</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">22177631</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Hori</surname><given-names>K</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Kwan</surname><given-names>P</given-names></name><name><surname>Ladak</surname><given-names>A</given-names></name><etal/></person-group><article-title>Toll-like receptors expressed by dermal fibroblasts contribute to hypertrophic scarring</article-title><source>J Cell Physiol</source><year>2011</year><volume>226</volume><issue>5</issue><fpage>1265</fpage><lpage>1273</lpage><pub-id pub-id-type="pmid">20945369</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname><given-names>S</given-names></name><name><surname>Grose</surname><given-names>R</given-names></name></person-group><article-title>Regulation of wound healing by growth factors and cytokines</article-title><source>Physiol Rev</source><year>2003</year><volume>83</volume><issue>3</issue><fpage>835</fpage><lpage>870</lpage><pub-id pub-id-type="pmid">12843410</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gurtner</surname><given-names>GC</given-names></name><name><surname>Werner</surname><given-names>S</given-names></name><name><surname>Barrandon</surname><given-names>Y</given-names></name><name><surname>Longaker</surname><given-names>MT</given-names></name></person-group><article-title>Wound repair and regeneration</article-title><source>Nature</source><year>2008</year><volume>453</volume><issue>7193</issue><fpage>314</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">18480812</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauglitz</surname><given-names>GG</given-names></name><name><surname>Korting</surname><given-names>HC</given-names></name><name><surname>Pavicic</surname><given-names>T</given-names></name><name><surname>Ruzicka</surname><given-names>T</given-names></name><name><surname>Jeschke</surname><given-names>MG</given-names></name></person-group><article-title>Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies</article-title><source>Mol Med</source><year>2011</year><volume>17</volume><issue>1&#x02013;2</issue><fpage>113</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">20927486</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finnerty</surname><given-names>CC</given-names></name><name><surname>Jeschke</surname><given-names>MG</given-names></name><name><surname>Branski</surname><given-names>LK</given-names></name><name><surname>Barret</surname><given-names>JP</given-names></name><name><surname>Dziewulski</surname><given-names>P</given-names></name><name><surname>Herndon</surname><given-names>DN</given-names></name></person-group><article-title>Hypertrophic scarring: the greatest unmet challenge after burn injury</article-title><source>Lancet</source><year>2016</year><volume>388</volume><issue>10052</issue><fpage>1427</fpage><lpage>1436</lpage><pub-id pub-id-type="pmid">27707499</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedstat</surname><given-names>JS</given-names></name><name><surname>Hultman</surname><given-names>CS</given-names></name></person-group><article-title>Hypertrophic burn scar management: what does the evidence show? A systematic review of randomized controlled trials</article-title><source>Ann Plast Surg</source><year>2014</year><volume>72</volume><issue>6</issue><fpage>S198</fpage><lpage>S201</lpage><pub-id pub-id-type="pmid">24835874</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>TH</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Ogawa</surname><given-names>R</given-names></name><name><surname>Suh</surname><given-names>JS</given-names></name><name><surname>Mustoe</surname><given-names>TA</given-names></name></person-group><article-title>Update on scar management: guidelines for treating Asian patients</article-title><source>Plast Reconstr Surg</source><year>2013</year><volume>132</volume><issue>6</issue><fpage>1580</fpage><lpage>1589</lpage><pub-id pub-id-type="pmid">24281584</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mustoe</surname><given-names>TA</given-names></name><name><surname>Cooter</surname><given-names>RD</given-names></name><name><surname>Gold</surname><given-names>MH</given-names></name><name><surname>Hobbs</surname><given-names>FD</given-names></name><name><surname>Ramelet</surname><given-names>AA</given-names></name><name><surname>Shakespeare</surname><given-names>PG</given-names></name><etal/></person-group><article-title>International clinical recommendations on scar management</article-title><source>Plast Reconstr Surg</source><year>2002</year><volume>110</volume><issue>2</issue><fpage>560</fpage><lpage>571</lpage><pub-id pub-id-type="pmid">12142678</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anzarut</surname><given-names>A</given-names></name><name><surname>Olson</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Rowe</surname><given-names>BH</given-names></name><name><surname>Tredget</surname><given-names>EE</given-names></name></person-group><article-title>The effectiveness of pressure garment therapy for the prevention of abnormal scarring after burn injury: a meta-analysis</article-title><source>J Plast Reconstr Aesthet Surg</source><year>2009</year><volume>62</volume><issue>1</issue><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">18249046</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stavrou</surname><given-names>D</given-names></name><name><surname>Weissman</surname><given-names>O</given-names></name><name><surname>Winkler</surname><given-names>E</given-names></name><name><surname>Yankelson</surname><given-names>L</given-names></name><name><surname>Millet</surname><given-names>E</given-names></name><name><surname>Mushin</surname><given-names>OP</given-names></name><etal/></person-group><article-title>Silicone-based scar therapy: a review of the literature</article-title><source>Aesthet Plast Surg</source><year>2010</year><volume>34</volume><issue>5</issue><fpage>646</fpage><lpage>651</lpage></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arno</surname><given-names>AI</given-names></name><name><surname>Gauglitz</surname><given-names>GG</given-names></name><name><surname>Barret</surname><given-names>JP</given-names></name><name><surname>Jeschke</surname><given-names>MG</given-names></name></person-group><article-title>Up-to-date approach to manage keloids and hypertrophic scars: a useful guide</article-title><source>Burns</source><year>2014</year><volume>40</volume><issue>7</issue><fpage>1255</fpage><lpage>1266</lpage><pub-id pub-id-type="pmid">24767715</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boutli-Kasapidou</surname><given-names>F</given-names></name><name><surname>Tsakiri</surname><given-names>A</given-names></name><name><surname>Anagnostou</surname><given-names>E</given-names></name><name><surname>Mourellou</surname><given-names>O</given-names></name></person-group><article-title>Hypertrophic and keloidal scars: an approach to polytherapy</article-title><source>Int J Dermatol</source><year>2005</year><volume>44</volume><issue>4</issue><fpage>324</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">15811088</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flickinger</surname><given-names>JC</given-names></name></person-group><article-title>A radiobiological analysis of multicenter data for postoperative keloid radiotherapy</article-title><source>Int J Radiat Oncol Biol Phys</source><year>2011</year><volume>79</volume><issue>4</issue><fpage>1164</fpage><lpage>1170</lpage><pub-id pub-id-type="pmid">20472370</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willows</surname><given-names>BM</given-names></name><name><surname>Ilyas</surname><given-names>M</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name></person-group><article-title>Laser in the management of burn scars</article-title><source>Burns</source><year>2017</year><volume>43</volume><issue>7</issue><fpage>1379</fpage><lpage>1389</lpage><pub-id pub-id-type="pmid">28784339</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tripathi</surname><given-names>PB</given-names></name><name><surname>Nelson</surname><given-names>JS</given-names></name><name><surname>Wong</surname><given-names>BJ</given-names></name></person-group><article-title>Posttraumatic laser treatment of soft tissue injury</article-title><source>Facial Plast Surg Clin North Am</source><year>2017</year><volume>25</volume><issue>4</issue><fpage>617</fpage><lpage>628</lpage><pub-id pub-id-type="pmid">28941513</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>MH</given-names></name><name><surname>McGuire</surname><given-names>M</given-names></name><name><surname>Mustoe</surname><given-names>TA</given-names></name><name><surname>Pusic</surname><given-names>A</given-names></name><name><surname>Sachdev</surname><given-names>M</given-names></name><name><surname>Waibel</surname><given-names>J</given-names></name><etal/></person-group><article-title>International Advisory Panel on Scar M: updated international clinical recommendations on scar management: part 2--algorithms for scar prevention and treatment</article-title><source>Dermatol Surg</source><year>2014</year><volume>40</volume><issue>8</issue><fpage>825</fpage><lpage>831</lpage><pub-id pub-id-type="pmid">25068544</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>RR</given-names></name><name><surname>Donelan</surname><given-names>MB</given-names></name><name><surname>Hivnor</surname><given-names>C</given-names></name><name><surname>Greeson</surname><given-names>E</given-names></name><name><surname>Ross</surname><given-names>EV</given-names></name><name><surname>Shumaker</surname><given-names>PR</given-names></name><etal/></person-group><article-title>Laser treatment of traumatic scars with an emphasis on ablative fractional laser resurfacing: consensus report</article-title><source>JAMA Dermatol</source><year>2014</year><volume>150</volume><issue>2</issue><fpage>187</fpage><lpage>193</lpage><pub-id pub-id-type="pmid">24336931</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>RR</given-names></name><name><surname>Parrish</surname><given-names>JA</given-names></name></person-group><article-title>Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation</article-title><source>Science</source><year>1983</year><volume>220</volume><issue>4596</issue><fpage>524</fpage><lpage>527</lpage><pub-id pub-id-type="pmid">6836297</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliaei</surname><given-names>S</given-names></name><name><surname>Nelson</surname><given-names>JS</given-names></name><name><surname>Fitzpatrick</surname><given-names>R</given-names></name><name><surname>Wong</surname><given-names>BJ</given-names></name></person-group><article-title>Laser treatment of scars</article-title><source>Facial Plast Surg</source><year>2012</year><volume>28</volume><issue>5</issue><fpage>518</fpage><lpage>524</lpage><pub-id pub-id-type="pmid">23027219</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Guan</surname><given-names>M</given-names></name><name><surname>Avram</surname><given-names>MM</given-names></name><etal/></person-group><article-title>The effect of flashlamp pulsed dye laser on the expression of connective tissue growth factor in keloids</article-title><source>Lasers Surg Med</source><year>2012</year><volume>44</volume><issue>5</issue><fpage>377</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">22539077</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Yue</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Guan</surname><given-names>M</given-names></name><etal/></person-group><article-title>The effect of 595 nm pulsed dye laser on connective tissue growth factor (CTGF) expression in cultured keloid fibroblasts</article-title><source>Lasers Surg Med</source><year>2015</year><volume>47</volume><issue>2</issue><fpage>203</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">25727552</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alster</surname><given-names>TS</given-names></name></person-group><article-title>Improvement of erythematous and hypertrophic scars by the 585-nm flashlamp-pumped pulsed dye laser</article-title><source>Ann Plast Surg</source><year>1994</year><volume>32</volume><issue>2</issue><fpage>186</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">8192370</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manuskiatti</surname><given-names>W</given-names></name><name><surname>Wanitphakdeedecha</surname><given-names>R</given-names></name><name><surname>Fitzpatrick</surname><given-names>RE</given-names></name></person-group><article-title>Effect of pulse width of a 595-nm flashlamp-pumped pulsed dye laser on the treatment response of keloidal and hypertrophic sternotomy scars</article-title><source>Dermatol Surg</source><year>2007</year><volume>33</volume><issue>2</issue><fpage>152</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">17300600</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>JK</given-names></name><name><surname>Burkes</surname><given-names>SA</given-names></name><name><surname>Visscher</surname><given-names>MO</given-names></name><name><surname>Whitestone</surname><given-names>J</given-names></name><name><surname>Kagan</surname><given-names>RJ</given-names></name><name><surname>Yakuboff</surname><given-names>KP</given-names></name><etal/></person-group><article-title>Multimodal quantitative analysis of early pulsed-dye laser treatment of scars at a pediatric burn hospital</article-title><source>Dermatol Surg</source><year>2012</year><volume>38</volume><issue>9</issue><fpage>1490</fpage><lpage>1496</lpage><pub-id pub-id-type="pmid">22672578</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nouri</surname><given-names>K</given-names></name><name><surname>Jimenez</surname><given-names>GP</given-names></name><name><surname>Harrison-Balestra</surname><given-names>C</given-names></name><name><surname>Elgart</surname><given-names>GW</given-names></name></person-group><article-title>585-nm pulsed dye laser in the treatment of surgical scars starting on the suture removal day</article-title><source>Dermatol Surg</source><year>2003</year><volume>29</volume><issue>1</issue><fpage>65</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">12534515</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>AK</given-names></name><name><surname>Tan</surname><given-names>OT</given-names></name><name><surname>Boll</surname><given-names>J</given-names></name><name><surname>Parrish</surname><given-names>JA</given-names></name><name><surname>Murphy</surname><given-names>GF</given-names></name></person-group><article-title>Ultrastructure: effects of melanin pigment on target specificity using a pulsed dye laser (577 nm)</article-title><source>J Invest Dermatol</source><year>1987</year><volume>88</volume><issue>6</issue><fpage>747</fpage><lpage>752</lpage><pub-id pub-id-type="pmid">3585058</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manstein</surname><given-names>D</given-names></name><name><surname>Herron</surname><given-names>GS</given-names></name><name><surname>Sink</surname><given-names>RK</given-names></name><name><surname>Tanner</surname><given-names>H</given-names></name><name><surname>Anderson</surname><given-names>RR</given-names></name></person-group><article-title>Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury</article-title><source>Lasers Surg Med</source><year>2004</year><volume>34</volume><issue>5</issue><fpage>426</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">15216537</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jih</surname><given-names>MH</given-names></name><name><surname>Kimyai-Asadi</surname><given-names>A</given-names></name></person-group><article-title>Fractional photothermolysis: a review and update</article-title><source>Semin Cutan Med Surg</source><year>2008</year><volume>27</volume><issue>1</issue><fpage>63</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">18486026</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uebelhoer</surname><given-names>NS</given-names></name><name><surname>Ross</surname><given-names>EV</given-names></name><name><surname>Shumaker</surname><given-names>PR</given-names></name></person-group><article-title>Ablative fractional resurfacing for the treatment of traumatic scars and contractures</article-title><source>Semin Cutan Med Surg</source><year>2012</year><volume>31</volume><issue>2</issue><fpage>110</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">22640431</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hantash</surname><given-names>BM</given-names></name><name><surname>Bedi</surname><given-names>VP</given-names></name><name><surname>Kapadia</surname><given-names>B</given-names></name><name><surname>Rahman</surname><given-names>Z</given-names></name><name><surname>Jiang</surname><given-names>K</given-names></name><name><surname>Tanner</surname><given-names>H</given-names></name><etal/></person-group><article-title>In vivo histological evaluation of a novel ablative fractional resurfacing device</article-title><source>Lasers Surg Med</source><year>2007</year><volume>39</volume><issue>2</issue><fpage>96</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">17311274</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laubach</surname><given-names>HJ</given-names></name><name><surname>Tannous</surname><given-names>Z</given-names></name><name><surname>Anderson</surname><given-names>RR</given-names></name><name><surname>Manstein</surname><given-names>D</given-names></name></person-group><article-title>Skin responses to fractional photothermolysis</article-title><source>Lasers Surg Med</source><year>2006</year><volume>38</volume><issue>2</issue><fpage>142</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">16392146</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozog</surname><given-names>DM</given-names></name><name><surname>Liu</surname><given-names>A</given-names></name><name><surname>Chaffins</surname><given-names>ML</given-names></name><name><surname>Ormsby</surname><given-names>AH</given-names></name><name><surname>Fincher</surname><given-names>EF</given-names></name><name><surname>Chipps</surname><given-names>LK</given-names></name><etal/></person-group><article-title>Evaluation of clinical results, histological architecture, and collagen expression following treatment of mature burn scars with a fractional carbon dioxide laser</article-title><source>JAMA Dermatol</source><year>2013</year><volume>149</volume><issue>1</issue><fpage>50</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">23069917</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>C</given-names></name><name><surname>Grossman</surname><given-names>PH</given-names></name><name><surname>Moy</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Clinical and molecular effects on mature burn scars after treatment with a fractional CO(2) laser</article-title><source>Lasers Surg Med</source><year>2012</year><volume>44</volume><issue>7</issue><fpage>517</fpage><lpage>524</lpage><pub-id pub-id-type="pmid">22907286</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taudorf</surname><given-names>EH</given-names></name><name><surname>Danielsen</surname><given-names>PL</given-names></name><name><surname>Paulsen</surname><given-names>IF</given-names></name><name><surname>Togsverd-Bo</surname><given-names>K</given-names></name><name><surname>Dierickx</surname><given-names>C</given-names></name><name><surname>Paasch</surname><given-names>U</given-names></name><etal/></person-group><article-title>Non-ablative fractional laser provides long-term improvement of mature burn scars--a randomized controlled trial with histological assessment</article-title><source>Lasers Surg Med</source><year>2015</year><volume>47</volume><issue>2</issue><fpage>141</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">25154734</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hultman</surname><given-names>CS</given-names></name><name><surname>Edkins</surname><given-names>RE</given-names></name><name><surname>Lee</surname><given-names>CN</given-names></name><name><surname>Calvert</surname><given-names>CT</given-names></name><name><surname>Cairns</surname><given-names>BA</given-names></name></person-group><article-title>Shine on: review of laser- and light-based therapies for the treatment of burn scars</article-title><source>Dermatol Res Pract</source><year>2012</year><volume>2012</volume><fpage>243651</fpage><pub-id pub-id-type="pmid">22778719</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Issler-Fisher</surname><given-names>AC</given-names></name><name><surname>Fisher</surname><given-names>OM</given-names></name><name><surname>Smialkowski</surname><given-names>AO</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>van Schalkwyk</surname><given-names>CP</given-names></name><name><surname>Haertsch</surname><given-names>P</given-names></name><etal/></person-group><article-title>Ablative fractional CO2 laser for burn scar reconstruction: an extensive subjective and objective short-term outcome analysis of a prospective treatment cohort</article-title><source>Burns</source><year>2017</year><volume>43</volume><issue>3</issue><fpage>573</fpage><lpage>582</lpage><pub-id pub-id-type="pmid">27707636</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwan</surname><given-names>JM</given-names></name><name><surname>Wyatt</surname><given-names>M</given-names></name><name><surname>Uebelhoer</surname><given-names>NS</given-names></name><name><surname>Pyo</surname><given-names>J</given-names></name><name><surname>Shumaker</surname><given-names>PR</given-names></name></person-group><article-title>Functional improvement after ablative fractional laser treatment of a scar contracture</article-title><source>PM R</source><year>2011</year><volume>3</volume><issue>10</issue><fpage>986</fpage><lpage>987</lpage><pub-id pub-id-type="pmid">22024331</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finney</surname><given-names>R</given-names></name><name><surname>Torbeck</surname><given-names>R</given-names></name><name><surname>Saedi</surname><given-names>N</given-names></name></person-group><article-title>Non-ablative fractional resurfacing in the treatment of scar contracture</article-title><source>Lasers Surg Med</source><year>2016</year><volume>48</volume><issue>2</issue><fpage>170</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">26251257</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waibel</surname><given-names>JS</given-names></name><name><surname>Wulkan</surname><given-names>AJ</given-names></name><name><surname>Shumaker</surname><given-names>PR</given-names></name></person-group><article-title>Treatment of hypertrophic scars using laser and laser assisted corticosteroid delivery</article-title><source>Lasers Surg Med</source><year>2013</year><volume>45</volume><issue>3</issue><fpage>135</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">23460557</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haedersdal</surname><given-names>M</given-names></name><name><surname>Erlendsson</surname><given-names>AM</given-names></name><name><surname>Paasch</surname><given-names>U</given-names></name><name><surname>Anderson</surname><given-names>RR</given-names></name></person-group><article-title>Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: a critical review from basics to current clinical status</article-title><source>J Am Acad Dermatol</source><year>2016</year><volume>74</volume><issue>5</issue><fpage>981</fpage><lpage>1004</lpage><pub-id pub-id-type="pmid">26936299</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choe</surname><given-names>JH</given-names></name><name><surname>Park</surname><given-names>YL</given-names></name><name><surname>Kim</surname><given-names>BJ</given-names></name><name><surname>Kim</surname><given-names>MN</given-names></name><name><surname>Rho</surname><given-names>NK</given-names></name><name><surname>Park</surname><given-names>BS</given-names></name><etal/></person-group><article-title>Prevention of thyroidectomy scar using a new 1,550-nm fractional erbium-glass laser</article-title><source>Dermatol Surg</source><year>2009</year><volume>35</volume><issue>8</issue><fpage>1199</fpage><lpage>1205</lpage><pub-id pub-id-type="pmid">19175371</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sobanko</surname><given-names>JF</given-names></name><name><surname>Vachiramon</surname><given-names>V</given-names></name><name><surname>Rattanaumpawan</surname><given-names>P</given-names></name><name><surname>Miller</surname><given-names>CJ</given-names></name></person-group><article-title>Early postoperative single treatment ablative fractional lasing of Mohs micrographic surgery facial scars: a split-scar, evaluator-blinded study</article-title><source>Lasers Surg Med</source><year>2015</year><volume>47</volume><issue>1</issue><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">25559589</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karmisholt</surname><given-names>KE</given-names></name><name><surname>Wenande</surname><given-names>E</given-names></name><name><surname>Thaysen-Petersen</surname><given-names>D</given-names></name><name><surname>Philipsen</surname><given-names>PA</given-names></name><name><surname>Paasch</surname><given-names>U</given-names></name><name><surname>Haedersdal</surname><given-names>M</given-names></name></person-group><article-title>Early intervention with non-ablative fractional laser to improve cutaneous scarring-a randomized controlled trial on the impact of intervention time and fluence levels</article-title><source>Lasers Surg Med</source><year>2018</year><volume>50</volume><issue>1</issue><fpage>28</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">28815643</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metelitsa</surname><given-names>AI</given-names></name><name><surname>Alster</surname><given-names>TS</given-names></name></person-group><article-title>Fractionated laser skin resurfacing treatment complications: a review</article-title><source>Dermatol Surg</source><year>2010</year><volume>36</volume><issue>3</issue><fpage>299</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">20100273</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>LZ</given-names></name><name><surname>Ding</surname><given-names>JP</given-names></name><name><surname>Yang</surname><given-names>MY</given-names></name><name><surname>Chen</surname><given-names>DW</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name></person-group><article-title>Treatment of facial post-burn hyperpigmentation using micro-plasma radiofrequency technology</article-title><source>Lasers Med Sci</source><year>2015</year><volume>30</volume><issue>1</issue><fpage>241</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">25209007</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halachmi</surname><given-names>S</given-names></name><name><surname>Orenstein</surname><given-names>A</given-names></name><name><surname>Meneghel</surname><given-names>T</given-names></name><name><surname>Lapidoth</surname><given-names>M</given-names></name></person-group><article-title>A novel fractional micro-plasma radio-frequency technology for the treatment of facial scars and rhytids: a pilot study</article-title><source>J Cosmet Laser Ther</source><year>2010</year><volume>12</volume><issue>5</issue><fpage>208</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">20825258</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kono</surname><given-names>T</given-names></name><name><surname>Groff</surname><given-names>WF</given-names></name><name><surname>Sakurai</surname><given-names>H</given-names></name><name><surname>Yamaki</surname><given-names>T</given-names></name><name><surname>Soejima</surname><given-names>K</given-names></name><name><surname>Nozaki</surname><given-names>M</given-names></name></person-group><article-title>Treatment of traumatic scars using plasma skin regeneration (PSR) system</article-title><source>Lasers Surg Med</source><year>2009</year><volume>41</volume><issue>2</issue><fpage>128</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">19226574</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Mi</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Jin</surname><given-names>R</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name></person-group><article-title>Fractional microplasma radiofrequency technology for non-hypertrophic post-burn scars in Asians: a prospective study of 95 patients</article-title><source>Lasers Surg Med</source><year>2017</year><volume>49</volume><issue>6</issue><fpage>563</fpage><lpage>569</lpage><pub-id pub-id-type="pmid">28220505</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>MK</given-names></name><name><surname>Choi</surname><given-names>JH</given-names></name><name><surname>Ahn</surname><given-names>SB</given-names></name><name><surname>Lee</surname><given-names>MH</given-names></name></person-group><article-title>Histologic comparison of microscopic treatment zones induced by fractional lasers and radiofrequency</article-title><source>J Cosmet Laser Ther</source><year>2014</year><volume>16</volume><issue>6</issue><fpage>317</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">25148410</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amini-Nik</surname><given-names>S</given-names></name><name><surname>Yousuf</surname><given-names>Y</given-names></name><name><surname>Jeschke</surname><given-names>MG</given-names></name></person-group><article-title>Scar management in burn injuries using drug delivery and molecular signaling: current treatments and future directions</article-title><source>Adv Drug Deliv Rev</source><year>2018</year><volume>123</volume><fpage>135</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">28757325</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trelles</surname><given-names>MA</given-names></name><name><surname>Martinez-Carpio</surname><given-names>PA</given-names></name></person-group><article-title>Clinical and histological results in the treatment of atrophic and hypertrophic scars using a combined method of radiofrequency, ultrasound, and transepidermal drug delivery</article-title><source>Int J Dermatol</source><year>2016</year><volume>55</volume><issue>8</issue><fpage>926</fpage><lpage>933</lpage><pub-id pub-id-type="pmid">26967960</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Issa</surname><given-names>MC</given-names></name><name><surname>Kassuga</surname><given-names>LE</given-names></name><name><surname>Chevrand</surname><given-names>NS</given-names></name><name><surname>Pires</surname><given-names>MT</given-names></name></person-group><article-title>Topical delivery of triamcinolone via skin pretreated with ablative radiofrequency: a new method in hypertrophic scar treatment</article-title><source>Int J Dermatol</source><year>2013</year><volume>52</volume><issue>3</issue><fpage>367</fpage><lpage>370</lpage><pub-id pub-id-type="pmid">23414164</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trelles</surname><given-names>MA</given-names></name><name><surname>Martinez-Carpio</surname><given-names>PA</given-names></name></person-group><article-title>Attenuation of acne scars using high power fractional ablative unipolar radiofrequency and ultrasound for transepidermal delivery of bioactive compounds through microchannels</article-title><source>Lasers Surg Med</source><year>2014</year><volume>46</volume><issue>2</issue><fpage>152</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">24474092</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paithankar</surname><given-names>D</given-names></name><name><surname>Hwang</surname><given-names>BH</given-names></name><name><surname>Munavalli</surname><given-names>G</given-names></name><name><surname>Kauvar</surname><given-names>A</given-names></name><name><surname>Lloyd</surname><given-names>J</given-names></name><name><surname>Blomgren</surname><given-names>R</given-names></name><etal/></person-group><article-title>Ultrasonic delivery of silica-gold nanoshells for photothermolysis of sebaceous glands in humans: nanotechnology from the bench to clinic</article-title><source>J Control Release</source><year>2015</year><volume>206</volume><fpage>30</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">25747145</pub-id></element-citation></ref></ref-list></back></article>